<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37575265</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Divergent functional outcomes of NLRP3 blockade downstream of multi-inflammasome activation: therapeutic implications for ALS.</ArticleTitle><Pagination><StartPage>1190219</StartPage><MedlinePgn>1190219</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1190219</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1190219</ELocationID><Abstract><AbstractText>NOD-Like Receptor Family Pyrin Domain Containing 3 (NLRP3) inflammasome modulation has emerged as a potential therapeutic approach targeting inflammation amplified by pyroptotic innate immune cell death. In diseases characterized by non-cell autonomous neurodegeneration including amyotrophic lateral sclerosis (ALS), the activation of several inflammasomes has been reported. Since functional redundancy can exist among inflammasome pathways, here we investigate the effects of NLRP3 inhibition on NLRP3, NLR family CARD Domain Containing 4 (NLRC4) and non-canonical pathways to understand whether NLRP3 blockade alone can mitigate pro-inflammatory cytokine release and pyroptotic cell death in contexts where single or multiple inflammasome pathways independent of NLRP3 are activated. In this study we do not limit our insights into inflammasome biology by solely relying on the THP-1 monocytic line under the LPS/nigericin-mediated NLRP3 pathway activation paradigm. We assess therapeutic potential and limitations of NLRP3 inhibition in multi-inflammasome activation contexts utilizing various human cellular systems including cell lines expressing gain of function (GoF) mutations for several inflammasomes, primary human monocytes, macrophages, healthy and Amyotrophic Lateral Sclerosis (ALS) patient induced pluripotent stem cells (iPSC)-derived microglia (iMGL) stimulated for canonical and non-canonical inflammasome pathways. We demonstrate that NLRP3 inhibition can modulate the NLRC4 and non-canonical inflammasome pathways; however, these effects differ between immortalized, human primary innate immune cells, and iMGL. We extend our investigation in more complex systems characterized by activation of multiple inflammasomes such as the SOD1<sup>G93A</sup> mouse model. Through deep immune phenotyping by single-cell mass cytometry we demonstrate that acute NLRP3 inhibition does not ameliorate spinal cord inflammation in this model. Taken together, our data suggests that NLRP3 inhibition alone may not be sufficient to address dynamic and complex neuroinflammatory pathobiological mechanisms including dysregulation of multiple inflammasome pathways in neurodegenerative disease such as ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Cl&#xe9;net, Keaney, Gillet, Valadas, Langlois, Cardenas, Gasser and Kadiu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cl&#xe9;net</LastName><ForeName>Marie-Laure</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Neuroinflammation Focus Area, Neuroscience Research, Early Solutions, UCB Biopharma SRL, Braine l'Alleud, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keaney</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neuroinflammation Focus Area, Neuroscience Research, Early Solutions, UCB Biopharma SRL, Braine l'Alleud, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillet</LastName><ForeName>Ga&#xeb;lle</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neuroinflammation Focus Area, Neuroscience Research, Early Solutions, UCB Biopharma SRL, Braine l'Alleud, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valadas</LastName><ForeName>Jorge S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Neuroinflammation Focus Area, Neuroscience Research, Early Solutions, UCB Biopharma SRL, Braine l'Alleud, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langlois</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neuroinflammation Focus Area, Neuroscience Research, Early Solutions, UCB Biopharma SRL, Braine l'Alleud, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardenas</LastName><ForeName>Alvaro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Development Science, Early Solutions, UCB Biopharma SRL, Braine l'Alleud, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gasser</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neuroinflammation Focus Area, Neuroscience Research, Early Solutions, UCB Biopharma SRL, Braine l'Alleud, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadiu</LastName><ForeName>Irena</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Neuroinflammation Focus Area, Neuroscience Research, Early Solutions, UCB Biopharma SRL, Braine l'Alleud, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071199">NLR Family, Pyrin Domain-Containing 3 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000070576">NLR Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058847" MajorTopicYN="N">Inflammasomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071199" MajorTopicYN="N">NLR Family, Pyrin Domain-Containing 3 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070576" MajorTopicYN="N">NLR Proteins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">MCC950</Keyword><Keyword MajorTopicYN="N">MEFV</Keyword><Keyword MajorTopicYN="N">NLRC4</Keyword><Keyword MajorTopicYN="N">NLRP1</Keyword><Keyword MajorTopicYN="N">NLRP3</Keyword><Keyword MajorTopicYN="N">iPSC-derived microglia</Keyword><Keyword MajorTopicYN="N">inflammasomes</Keyword></KeywordList><CoiStatement>The authors declare that this study was funded in its entirety by UCB Biopharma SRL. The funder had the following involvement in the study: all authors were employees of UCB at the time of execution of the study. The funder was involved in the funding of the study in its entirety, as well study design, collection, analysis, interpretation of data, the writing of this article, and the decision to submit it for publication.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37575265</ArticleId><ArticleId IdType="pmc">PMC10415077</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1190219</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, et al. . Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U.S.A. (2006) 103(43):16021&#x2013;6. doi:&#xa0;10.1073/pnas.0607423103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0607423103</ArticleId><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, et al. . Onset and progression in inherited ALS determined by motor neurons and microglia. Science (2006) 312(5778):1389&#x2013;92. doi: 10.1126/science.1123511</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Libon DJ, Toledo JB, Xie SX, McCluskey L, Elman L, et al. . Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis. Acta Neuropathol (2012) 123(3):395&#x2013;407. doi: 10.1007/s00401-011-0932-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0932-x</ArticleId><ArticleId IdType="pmc">PMC3595560</ArticleId><ArticleId IdType="pubmed">22210083</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Toledo JB, Van Deerlin VM, Elman L, McCluskey L, Lee VM, et al. . Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PloS One (2012) 7(6):e39216. doi: 10.1371/journal.pone.0039216</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039216</ArticleId><ArticleId IdType="pmc">PMC3375234</ArticleId><ArticleId IdType="pubmed">22720079</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci (2007) 10(5):608&#x2013;14. doi: 10.1038/nn1885</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1885</ArticleId><ArticleId IdType="pmc">PMC3139463</ArticleId><ArticleId IdType="pubmed">17435754</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, Miranda CJ, et al. . Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron (2014) 81(5):1009&#x2013;23. doi: 10.1016/j.neuron.2014.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Lall D, Baloh RH. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J Clin Invest (2017) 127(9):3250&#x2013;8. doi: 10.1172/JCI90607</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90607</ArticleId><ArticleId IdType="pmc">PMC5669558</ArticleId><ArticleId IdType="pubmed">28737506</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, et al. . Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci (2008) 11(3):251&#x2013;3. doi: 10.1038/nn2047</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiot A, Za&#xef;di S, Iltis C, Ribon M, Berriat F, Schiaffino L, et al. . Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival. Nat Neurosci (2020) 23(11):1339&#x2013;51. doi: 10.1038/s41593-020-00718-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00718-z</ArticleId><ArticleId IdType="pubmed">33077946</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, King PH, Si Y, Kwon Y, Varela V, Ibarburu S, et al. . Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. JCI Insight (2018) 3(19). doi: 10.1172/jci.insight.123249</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.123249</ArticleId><ArticleId IdType="pmc">PMC6237484</ArticleId><ArticleId IdType="pubmed">30282815</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Muriana A, Mancuso R, Francos-Quijorna I, Olmos-Alonso A, Osta R, Perry VH, et al. . CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves. Sci Rep (2016) 6:25663. doi: 10.1038/srep25663</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25663</ArticleId><ArticleId IdType="pmc">PMC4865981</ArticleId><ArticleId IdType="pubmed">27174644</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dyke JM, Smit-Oistad IM, Macrander C, Krakora D, Meyer MG, Suzuki M. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS). Exp Neurol (2016) 277:275&#x2013;82. doi: 10.1016/j.expneurol.2016.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.01.008</ArticleId><ArticleId IdType="pmc">PMC4762214</ArticleId><ArticleId IdType="pubmed">26775178</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong T, Liu L, Jiang W, Zhou R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol (2020) 20(2):95&#x2013;112. doi: 10.1038/s41577-019-0215-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0215-7</ArticleId><ArticleId IdType="pubmed">31558839</ArticleId></ArticleIdList></Reference><Reference><Citation>Platnich JM, Muruve DA. NOD-like receptors and inflammasomes: A review of their canonical and non-canonical signaling pathways. Arch Biochem biophys (2019) 670:4&#x2013;14. doi: 10.1016/j.abb.2019.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2019.02.008</ArticleId><ArticleId IdType="pubmed">30772258</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie BA, Dixit VM, Power C. Fiery cell death: pyroptosis in the central nervous system. Trends Neurosci (2020) 43(1):55&#x2013;73. doi: 10.1016/j.tins.2019.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2019.11.005</ArticleId><ArticleId IdType="pubmed">31843293</ArticleId></ArticleIdList></Reference><Reference><Citation>Voet S, Srinivasan S, Lamkanfi M, van Loo G. Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med (2019) 11(6). doi: 10.15252/emmm.201810248</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201810248</ArticleId><ArticleId IdType="pmc">PMC6554670</ArticleId><ArticleId IdType="pubmed">31015277</ArticleId></ArticleIdList></Reference><Reference><Citation>Johann S, Heitzer M, Kanagaratnam M, Goswami A, Rizo T, Weis J, et al. . NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Glia (2015) 63(12):2260&#x2013;73. doi: 10.1002/glia.22891</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22891</ArticleId><ArticleId IdType="pubmed">26200799</ArticleId></ArticleIdList></Reference><Reference><Citation>Gugliandolo A, Giacoppo S, Bramanti P, Mazzon E. NLRP3 inflammasome activation in a transgenic amyotrophic lateral sclerosis model. Inflammation (2018) 41(1):93&#x2013;103. doi: 10.1007/s10753-017-0667-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-017-0667-5</ArticleId><ArticleId IdType="pubmed">28936769</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellezza I, Grottelli S, Costanzi E, Scarpelli P, Pigna E, Morozzi G, et al. . Peroxynitrite activates the NLRP3 inflammasome cascade in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Mol Neurobiol (2018) 55(3):2350&#x2013;61. doi: 10.1007/s12035-017-0502-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0502-x</ArticleId><ArticleId IdType="pubmed">28357805</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann S, Esch E, Hartmann P, Goswami A, Nikolin S, Weis J, et al. . Expression profile of pattern recognition receptors in skeletal muscle of SOD1((G93A)) amyotrophic lateral sclerosis (ALS) mice and sporadic ALS patients. Neuropathol Appl Neurobiol (2018) 44(6):606&#x2013;27. doi: 10.1111/nan.12483</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12483</ArticleId><ArticleId IdType="pubmed">29575052</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Garc&#xed;a L, Miana-Mena FJ, Moreno-Mart&#xed;nez L, de la Torre M, Lunetta C, Tarlarini C, et al. . Inflammasome in ALS skeletal muscle: NLRP3 as a potential biomarker. Int J Mol Sci (2021) 22(5). doi: 10.3390/ijms22052523</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052523</ArticleId><ArticleId IdType="pmc">PMC7959138</ArticleId><ArticleId IdType="pubmed">33802349</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner F, Molawi K, Zychlinsky A. Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. Proc Natl Acad Sci U S A (2010) 107(29):13046&#x2013;50. doi: 10.1073/pnas.1002396107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1002396107</ArticleId><ArticleId IdType="pmc">PMC2919927</ArticleId><ArticleId IdType="pubmed">20616033</ArticleId></ArticleIdList></Reference><Reference><Citation>Deora V, Lee JD, Albornoz EA, McAlary L, Jagaraj CJ, Robertson AAB, et al. . The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia (2020) 68(2):407&#x2013;21. doi: 10.1002/glia.23728</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23728</ArticleId><ArticleId IdType="pubmed">31596526</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Bell S, Wang J, Wen S, Baloh RH, et al. . TDP-43 activates microglia through NF-&#x3ba;B and NLRP3 inflammasome. Exp Neurol (2015) 273:24&#x2013;35. doi: 10.1016/j.expneurol.2015.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.07.019</ArticleId><ArticleId IdType="pubmed">26222336</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin P, Guo X, Yang W, Yan S, Yang S, Zhao T, et al. . Caspase-4 mediates cytoplasmic accumulation of TDP-43 in the primate brains. Acta Neuropathol (2019) 137(6):919&#x2013;37. doi: 10.1007/s00401-019-01979-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01979-0</ArticleId><ArticleId IdType="pmc">PMC6531422</ArticleId><ArticleId IdType="pubmed">30810811</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SJ, Sanchez I, Jing N, Yuan J. Dissociation between neurodegeneration and caspase-11-mediated activation of caspase-1 and caspase-3 in a mouse model of amyotrophic lateral sclerosis. J Neurosci (2003) 23(13):5455&#x2013;60. doi: 10.1523/JNEUROSCI.23-13-05455.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-13-05455.2003</ArticleId><ArticleId IdType="pmc">PMC6741245</ArticleId><ArticleId IdType="pubmed">12843244</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigrovic PA, Lee PY, Hoffman HM. Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach. J Allergy Clin Immunol (2020) 146(5):925&#x2013;37. doi: 10.1016/j.jaci.2020.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.08.017</ArticleId><ArticleId IdType="pmc">PMC7727443</ArticleId><ArticleId IdType="pubmed">33160483</ArticleId></ArticleIdList></Reference><Reference><Citation>Albornoz EA, Woodruff TM, Gordon R. Inflammasomes in CNS diseases. Exp Suppl (2018) 108:41&#x2013;60. doi: 10.1007/978-3-319-89390-7_3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-89390-7_3</ArticleId><ArticleId IdType="pubmed">30536167</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaidt MM, Ebert TS, Chauhan D, Ramshorn K, Pinci F, Zuber S, et al. . The DNA inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3. Cell (2017) 171(5):1110&#x2013;24.e18. doi:&#xa0;10.1111/acel.12946</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12946</ArticleId><ArticleId IdType="pmc">PMC5901709</ArticleId><ArticleId IdType="pubmed">29033128</ArticleId></ArticleIdList></Reference><Reference><Citation>Bierschenk D, Monteleone M, Moghaddas F, Baker PJ, Masters SL, Boucher D, et al. . The Salmonella pathogenicity island-2 subverts human NLRP3 and NLRC4 inflammasome responses. J Leukoc Biol (2019) 105(2):401&#x2013;10. doi: 10.1002/JLB.MA0318-112RR</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.MA0318-112RR</ArticleId><ArticleId IdType="pubmed">30368901</ArticleId></ArticleIdList></Reference><Reference><Citation>Gram AM, Wright JA, Pickering RJ, Lam NL, Booty LM, Webster SJ, et al. . Salmonella flagellin activates NAIP/NLRC4 and canonical NLRP3 inflammasomes in human macrophages. J Immunol (2021) 206(3):631&#x2013;40. doi: 10.4049/jimmunol.2000382</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000382</ArticleId><ArticleId IdType="pmc">PMC7812056</ArticleId><ArticleId IdType="pubmed">33380493</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu Y, Misaghi S, Newton K, Maltzman A, Izrael-Tomasevic A, Arnott D, et al. . NLRP3 recruitment by NLRC4 during Salmonella infection. J Exp Med (2016) 213(6):877&#x2013;85. doi: 10.1084/jem.20132234</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20132234</ArticleId><ArticleId IdType="pmc">PMC4886354</ArticleId><ArticleId IdType="pubmed">27139490</ArticleId></ArticleIdList></Reference><Reference><Citation>Broz P, Newton K, Lamkanfi M, Mariathasan S, Dixit VM, Monack DM. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J Exp Med (2010) 207(8):1745&#x2013;55. doi: 10.1084/jem.20100257</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20100257</ArticleId><ArticleId IdType="pmc">PMC2916133</ArticleId><ArticleId IdType="pubmed">20603313</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker PJ, Boucher D, Bierschenk D, Tebartz C, Whitney PG, D&#x2019;Silva DB, et al. . NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5. Eur J Immunol (2015) 45(10):2918&#x2013;26. doi: 10.1002/eji.201545655</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201545655</ArticleId><ArticleId IdType="pubmed">26173988</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid-Burgk JL, Gaidt MM, Schmidt T, Ebert TS, Bartok E, Hornung V. Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells. Eur J Immunol (2015) 45(10):2911&#x2013;7. doi: 10.1002/eji.201545523</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201545523</ArticleId><ArticleId IdType="pubmed">26174085</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfc;hl S, Broz P. Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux. Eur J Immunol (2015) 45(10):2927&#x2013;36. doi: 10.1002/eji.201545772</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201545772</ArticleId><ArticleId IdType="pubmed">26173909</ArticleId></ArticleIdList></Reference><Reference><Citation>Abud EM, Ramirez RN, Martinez ES, Healy LM, Nguyen CHH, Newman SA, et al. . iPSC-derived human microglia-like cells to study neurological diseases. Neuron (2017) 94(2):278&#x2013;93 e9. doi: 10.1016/j.neuron.2017.03.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.03.042</ArticleId><ArticleId IdType="pmc">PMC5482419</ArticleId><ArticleId IdType="pubmed">28426964</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarda G, Zenger M, Yazdi AS, Schroder K, Ferrero I, Menu P, et al. . Differential expression of NLRP3 among hematopoietic cells. J Immunol (2011) 186(4):2529&#x2013;34. doi: 10.4049/jimmunol.1002720</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1002720</ArticleId><ArticleId IdType="pubmed">21257968</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhl&#xe9;n M, Fagerberg L, Hallstr&#xf6;m BM, Lindskog C, Oksvold P, Mardinoglu A, et al. . Proteomics. Tissue-based map of the human proteome. Science (2015) 347(6220):1260419. doi:&#xa0;10.1126/science.126041</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.126041</ArticleId><ArticleId IdType="pubmed">25613900</ArticleId></ArticleIdList></Reference><Reference><Citation>
The Human Protein Atlas . Available at: http://www.proteinatlas.org/.</Citation></Reference><Reference><Citation>Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD, et al. . Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron (2016) 89(1):37&#x2013;53. doi: 10.1016/j.neuron.2015.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.11.013</ArticleId><ArticleId IdType="pmc">PMC4707064</ArticleId><ArticleId IdType="pubmed">26687838</ArticleId></ArticleIdList></Reference><Reference><Citation>
Brain RNA-Seq . Available at: https://www.brainrnaseq.org/.</Citation></Reference><Reference><Citation>Yang Y, Wang H, Kouadir M, Song H, Shi F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis (2019) 10(2):128. doi: 10.1038/s41419-019-1413-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1413-8</ArticleId><ArticleId IdType="pmc">PMC6372664</ArticleId><ArticleId IdType="pubmed">30755589</ArticleId></ArticleIdList></Reference><Reference><Citation>Coll RC, Robertson AA, Chae JJ, Higgins SC, Mu&#xf1;oz-Planillo R, Inserra MC, et al. . A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med (2015) 21(3):248&#x2013;55. doi: 10.1038/nm.3806</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3806</ArticleId><ArticleId IdType="pmc">PMC4392179</ArticleId><ArticleId IdType="pubmed">25686105</ArticleId></ArticleIdList></Reference><Reference><Citation>Primiano MJ, Lefker BA, Bowman MR, Bree AG, Hubeau C, Bonin PD, et al. . Efficacy and pharmacology of the NLRP3 inflammasome inhibitor CP-456,773 (CRID3) in murine models of dermal and pulmonary inflammation. J Immunol (2016) 197(6):2421&#x2013;33. doi: 10.4049/jimmunol.1600035</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1600035</ArticleId><ArticleId IdType="pubmed">27521339</ArticleId></ArticleIdList></Reference><Reference><Citation>Rui W, Xiao H, Fan Y, Ma Z, Xiao M, Li S, et al. . Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer&#x2019;s disease. J Neuroinflammation (2021) 18(1):280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8638109</ArticleId><ArticleId IdType="pubmed">34856990</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman L, Guo H, David CN, Brickey WJ, Jha S, Ting JP. NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes. J Exp Med (2017) 214(5):1351&#x2013;70. doi: 10.1084/jem.20150237</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20150237</ArticleId><ArticleId IdType="pmc">PMC5413320</ArticleId><ArticleId IdType="pubmed">28404595</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan JA, Canna SW. The NLRC4 inflammasome. Immunol Rev (2018) 281(1):115&#x2013;23. doi: 10.1111/imr.12607</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12607</ArticleId><ArticleId IdType="pmc">PMC5897049</ArticleId><ArticleId IdType="pubmed">29247997</ArticleId></ArticleIdList></Reference><Reference><Citation>Felderhoff-Mueser U, Schmidt OI, Oberholzer A, Buhrer C, Stahel PF. IL-18: a key player in neuroinflammation and neurodegeneration? Trends Neurosci (2005) 28(9):487&#x2013;93. doi: 10.1016/j.tins.2005.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2005.06.008</ArticleId><ArticleId IdType="pubmed">16023742</ArticleId></ArticleIdList></Reference><Reference><Citation>Matikainen S, Nyman TA, Cypryk W. Function and regulation of noncanonical caspase-4/5/11 inflammasome. J Immunol (2020) 204(12):3063&#x2013;9. doi: 10.4049/jimmunol.2000373</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000373</ArticleId><ArticleId IdType="pubmed">32513874</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaidt MM, Ebert TS, Chauhan D, Ramshorn K, Pinci F, Zuber S, et al. . The DNA inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3. Cell (2017) 171(5):1110&#x2013;24 e18. doi: 10.1016/j.cell.2017.09.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.09.039</ArticleId><ArticleId IdType="pmc">PMC5901709</ArticleId><ArticleId IdType="pubmed">29033128</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiggins KA, Parry AJ, Cassidy LD, Humphry M, Webster SJ, Goodall JC, et al. . IL-1&#x3b1; cleavage by inflammatory caspases of the noncanonical inflammasome controls the senescence-associated secretory phenotype. Aging Cell (2019) 18(3):e12946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6516163</ArticleId><ArticleId IdType="pubmed">30916891</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci (2019) 20(13). doi: 10.3390/ijms20133328</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20133328</ArticleId><ArticleId IdType="pmc">PMC6651423</ArticleId><ArticleId IdType="pubmed">31284572</ArticleId></ArticleIdList></Reference><Reference><Citation>Stieber A, Gonatas JO, Gonatas NK. Aggregates of mutant protein appear progressively in dendrites, in periaxonal processes of oligodendrocytes, and in neuronal and astrocytic perikarya of mice expressing the SOD1G93A mutation of familial amyotrophic lateral sclerosis. J Neurological Sci (2000) 177(2):114&#x2013;23. doi: 10.1016/S0022-510X(00)00351-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(00)00351-8</ArticleId><ArticleId IdType="pubmed">10980307</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, Jedrychowski MP, Cialic R, Krasemann S, Murugaiyan G, Fanek Z, et al. . Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol (2015) 77(1):75&#x2013;99. doi: 10.1002/ana.24304</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24304</ArticleId><ArticleId IdType="pmc">PMC4432483</ArticleId><ArticleId IdType="pubmed">25381879</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman-Patterson TD, Deitch JS, Blankenhorn EP, Erwin KL, Perreault MJ, Alexander BK, et al. . Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J Neurol Sci (2005) 236(1-2):1&#x2013;7. doi: 10.1016/j.jns.2005.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.02.006</ArticleId><ArticleId IdType="pubmed">16024047</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel C, Leylamian O, Posch A, Weis J, Aronica E, Beyer C, et al. . Expression and Cell Type-specific Localization of Inflammasome Sensors in the Spinal Cord of SOD1((G93A)) Mice and Sporadic Amyotrophic lateral sclerosis Patients. Neuroscience (2021) 463:288&#x2013;302. doi: 10.1016/j.neuroscience.2021.03.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2021.03.023</ArticleId><ArticleId IdType="pubmed">33781799</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S, et al. . Inflammasome inhibition prevents &#x3b1;-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med (2018) 10(465). doi: 10.1126/scitranslmed.aah4066</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aah4066</ArticleId><ArticleId IdType="pmc">PMC6483075</ArticleId><ArticleId IdType="pubmed">30381407</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, McManus RM, Latz E. Inflammasome signalling in brain function and neurodegenerative disease. Nat Rev Neurosci (2018) 19(10):610&#x2013;21. doi: 10.1038/s41583-018-0055-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-018-0055-7</ArticleId><ArticleId IdType="pubmed">30206330</ArticleId></ArticleIdList></Reference><Reference><Citation>Kortmann J, Brubaker SW, Monack DM. Cutting edge: inflammasome activation in primary human macrophages is dependent on flagellin. J Immunol (2015) 195(3):815&#x2013;9. doi: 10.4049/jimmunol.1403100</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1403100</ArticleId><ArticleId IdType="pmc">PMC4505955</ArticleId><ArticleId IdType="pubmed">26109648</ArticleId></ArticleIdList></Reference><Reference><Citation>Burm SM, Zuiderwijk-Sick EA, t Jong AE, van der Putten C, Veth J, Kondova I, et al. . Inflammasome-induced IL-1&#x3b2; secretion in microglia is characterized by delayed kinetics and is only partially dependent on inflammatory caspases. J Neurosci (2015) 35(2):678&#x2013;87. doi: 10.1523/JNEUROSCI.2510-14.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2510-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605364</ArticleId><ArticleId IdType="pubmed">25589762</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexianu ME, Kozovska M, Appel SH. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology (2001) 57(7):1282&#x2013;9. doi: 10.1212/WNL.57.7.1282</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.57.7.1282</ArticleId><ArticleId IdType="pubmed">11591849</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S, &#xc4;ij&#xf6; T, Vickovic S, Braine C, Kang K, Mollbrink A, et al. . Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science (2019) 364(6435):89&#x2013;93. doi: 10.1126/science.aav9776</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav9776</ArticleId><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis KE, Rasmussen AL, Bennett W, King A, West AK, Chung RS, et al. . Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase. J Neuroinflammation (2014) 11:55. doi: 10.1186/1742-2094-11-55</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-55</ArticleId><ArticleId IdType="pmc">PMC3994340</ArticleId><ArticleId IdType="pubmed">24655927</ArticleId></ArticleIdList></Reference><Reference><Citation>Stancu IC, Cremers N, Vanrusselt H, Couturier J, Vanoosthuyse A, Kessels S, et al. . Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo. Acta Neuropathol (2019) 137(4):599&#x2013;617. doi: 10.1007/s00401-018-01957-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-01957-y</ArticleId><ArticleId IdType="pmc">PMC6426830</ArticleId><ArticleId IdType="pubmed">30721409</ArticleId></ArticleIdList></Reference><Reference><Citation>Dempsey C, Rubio Araiz A, Bryson KJ, Finucane O, Larkin C, Mills EL, et al. . Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-&#x3b2; and cognitive function in APP/PS1 mice. Brain behavior immunity (2017) 61:306&#x2013;16. doi: 10.1016/j.bbi.2016.12.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2016.12.014</ArticleId><ArticleId IdType="pubmed">28003153</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonnemann N, Hosseini S, Marchetti C, Skouras DB, Stefanoni D, D&#x2019;Alessandro A, et al. . The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer&#x2019;s disease. Proc Natl Acad Sci U S A (2020) 117(50):32145&#x2013;54. doi: 10.1073/pnas.2009680117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2009680117</ArticleId><ArticleId IdType="pmc">PMC7749353</ArticleId><ArticleId IdType="pubmed">33257576</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>